Bahrain has approved Johnson & Johnson’s one-dose COVID-19 vaccine for emergency use, the first country to do so, the National Health Regulatory Authority said.
The small Gulf state already offers citizens and residents four vaccines free of charge: the Pfizer vaccine, one manufactured by Chinese state-backed pharmaceutical giant Sinopharm, the AstraZeneca COVID-19 vaccine and Russia’s Sputnik V.
NHRA said the J&J vaccine was for groups at greater risk of developing complications from COVID-19, including the elderly and people with chronic diseases.
NHRA’s CEO said, “An in-depth study had been conducted on all documents submitted by the company, which included the results of the clinical trials conducted.”
The United States Food and Drug Administration said the Johnson & Johnson shot appeared safe and effective in trials, paving the way for its approval for emergency use in the U.S. this month.